FLUDARABINE-TREOSULFAN REDUCED INTENSITY CONDITIONING REGIMEN PRIOR HAPLOIDENTICAL STEM CELL TRANSPLANTATION WITH POST TRANSPLANTATION CYCLOPHOSPHAMIDE FOR OLDER AND/OR FRAIL PATIENTS WITH AML
Clinical trial NCT07598110 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07598110
- Sponsor
- Institut Paoli-Calmettes
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-10-10
- Primary completion
- 2030-10-10
- Enrollment
- 77
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.